Mount Yale Investment Advisors »

Amicus Therapeutics shares owned by Mount Yale Investment Advisors

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Mount Yale Investment Advisors from 13F filings

Historical chart of Mount Yale Investment Advisors investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Mount Yale Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Mount Yale Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0M 376k 7.88
2024-06-30 $113k 11k 9.92
2024-03-31 $135k 11k 11.78
2023-09-30 $135k 11k 12.16

More positions owned by Mount Yale Investment Advisors

Vanguard Index Fds Sp 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
First Tr Exchangetraded Fst Low Oppt Eft (LMBS)
Spdr Series Trust Portfolio Agrgte (SPAB)
Schwab Strategic Tr Us Aggregate B (SCHZ)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Scottsdale Fds Intterm Corp (VCIT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Ishares Tr Core Sp Mcp Etf (IJH)

View all positions for Mount Yale Investment Advisors

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Pictet Asset Management Holding SA
Perceptive Advisors
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics